2024 @newlimit:
- 10X Engine throughput
- Discovered TF sets that reprogram cell age & preserve cell type
- Restored youthful function in a liver disease model with drug-like reprogramming
we demonstrated that reprogramming medicines are possible
2025: we start to develop them
Biohacking will change the world sooner that what people think 🌏
@CompoundVC we've dove deep into the space from working with companies to experimenting with products to engaging with different types of communities, and more. We've taken these learnings and done an in-depth exploration into the future of biohacking.
If you're interested in learning more or spending time in this space we're hosting a Biohacker Research Day with @usv on Sept 19 in NYC (and there may be a full zine then!).
We have a few slots left so DM if you're interested in attending and enjoy A Biohacker Future research day 🦾
Thanks to all the help from the Compound team from thoughtful convo's with @mhdempsey and @mackenziejem. And for the inspo from A Crypto Future @0xsmac 🤝
Thrilled that @factorialBio is joining the @ginkgo platform!
Life science tools is a great industry and could benefit from the scale of R&D platform infra that ginkgo has built for therapeutics.
Would love to see more of this - reach out to accelerate your tools research!🌱🧬
Ginkgo Bioworks is working on optimizing the manufacturing process for RNA – the key ingredient in vaccines produced by Pfizer/BioNtech and Moderna. RNA instructs cells to produce proteins that trigger the body to fight the coronavirus. https://t.co/w7tcvlUjpz